ORCID as entered in ROS

Select Publications
2025, 'Primary care follow-up of patients after attending a fracture liaison service: an integrative review', Archives of Osteoporosis, 20, http://dx.doi.org/10.1007/s11657-025-01521-8
,2025, 'Excess subsequent fracture and mortality risk after ankle fractures: a relative survival analysis of the 45 and Up Study', Osteoporosis International, 36, pp. 1031 - 1038, http://dx.doi.org/10.1007/s00198-025-07400-9
,2025, 'Rheumatoid arthritis and subsequent fracture risk: an individual person meta-analysis to update FRAX', Osteoporosis International, 36, pp. 653 - 671, http://dx.doi.org/10.1007/s00198-025-07397-1
,2025, 'Denosumab discontinuation in the clinic: implications of rebound bone turnover and emerging strategies to prevent bone loss and fractures.', J Bone Miner Res, http://dx.doi.org/10.1093/jbmr/zjaf037
,2025, 'Association between the Sp1-binding-site polymorphism in the collagen type I alpha 1 (COLIA1) gene and bone phenotypes: the Dubbo Osteoporosis Epidemiology Study', Journal of Bone and Mineral Metabolism, 43, pp. 114 - 122, http://dx.doi.org/10.1007/s00774-024-01558-8
,2025, 'Early and multiple doses of zoledronate mitigates rebound bone loss following withdrawal of receptor activator of nuclear factor kappa-B ligand inhibition', Journal of Bone and Mineral Research, 40, pp. 413 - 427, http://dx.doi.org/10.1093/jbmr/zjaf008
,2025, 'Response to the Letter by Yi Wang: “Reflections on ‘sex-differential testosterone response to long-term weight loss’: illuminating findings and considered limitations”: Bariatric Surgery', International Journal of Obesity, 49, pp. 538 - 539, http://dx.doi.org/10.1038/s41366-024-01692-3
,2025, 'Romosozumab as Treatment for Severe Osteoporosis in Heart and Lung Transplant Recipients', Endocrines, 6, http://dx.doi.org/10.3390/endocrines6010002
,2025, 'Osteoporosis screening in Australian community pharmacies: A mixed methods study', Health Promotion Journal of Australia, 36, http://dx.doi.org/10.1002/hpja.876
,2025, 'The design and evaluation of a bone health teaching module for secondary school students in NSW, Australia', Health Promotion Journal of Australia, 36, http://dx.doi.org/10.1002/hpja.931
,2024, 'A pilot feasibility randomised controlled trial of bone antiresorptive agents on bone turnover markers in critically ill women', Scientific Reports, 14, http://dx.doi.org/10.1038/s41598-024-52607-1
,2024, 'Defining the key clinician skills and attributes for competency managing patients with osteoporosis and fragility fractures', Journal of Bone and Mineral Research, 39, pp. 1835 - 1836, http://dx.doi.org/10.1093/jbmr/zjae146
,2024, 'The Fracture Phenotypes in Women and Men of 50 Years and Older with a Recent Clinical Fracture', Current Osteoporosis Reports, 22, pp. 611 - 620, http://dx.doi.org/10.1007/s11914-024-00885-z
,2024, 'Fracture risk assessment in the presence of competing risk of death', Osteoporosis International, 35, pp. 1989 - 1998, http://dx.doi.org/10.1007/s00198-024-07224-z
,2024, 'Fracture risk revisited: Bone mineral density T-score and fracture risk in type 2 diabetes', Diabetes Obesity and Metabolism, 26, pp. 5325 - 5335, http://dx.doi.org/10.1111/dom.15890
,2024, 'Correction: Sex-differential testosterone response to long-term weight loss (International Journal of Obesity, (2024), 10.1038/s41366-024-01591-7)', International Journal of Obesity, 48, pp. 1514, http://dx.doi.org/10.1038/s41366-024-01597-1
,2024, 'Sex-differential testosterone response to long-term weight loss', International Journal of Obesity, 48, pp. 1481 - 1488, http://dx.doi.org/10.1038/s41366-024-01591-7
,2024, 'Femoral neck width and hip fracture risk', Journal of Bone and Mineral Research, 39, pp. 1201 - 1202, http://dx.doi.org/10.1093/jbmr/zjae113
,2024, 'The evaluation of an osteoporosis medication management service in community pharmacy, a cohort study', Exploratory Research in Clinical and Social Pharmacy, 15, http://dx.doi.org/10.1016/j.rcsop.2024.100488
,2024, 'Author response to an editorial', Osteoporosis International, 35, pp. 1477 - 1478, http://dx.doi.org/10.1007/s00198-024-07157-7
,2024, 'Bone metabolism in diabetes: a clinician’s guide to understanding the bone–glucose interplay', Diabetologia, 67, pp. 1493 - 1506, http://dx.doi.org/10.1007/s00125-024-06172-x
,2024, 'Multimorbidity clusters potentially superior to individual diseases for stratifying fracture risk in older people: a nationwide cohort study', Age and Ageing, 53, http://dx.doi.org/10.1093/ageing/afae164
,2024, 'Health Perceptions, Multimorbidity, and New Fractures and Mortality among Patients with a Fracture', JAMA Network Open, 7, pp. E248491, http://dx.doi.org/10.1001/jamanetworkopen.2024.8491
,2024, 'Effect of denosumab on inflammation and bone health in active Charcot foot: A phase II randomised controlled trial', Journal of Diabetes and Its Complications, 38, http://dx.doi.org/10.1016/j.jdiacomp.2024.108718
,2024, 'Temporal patterns of osteoclast formation and activity following withdrawal of RANKL inhibition', Journal of Bone and Mineral Research, 39, pp. 484 - 497, http://dx.doi.org/10.1093/jbmr/zjae023
,2024, 'Expanding access to fracture liaison services in Australia for people with minimal trauma fractures: a system dynamics modelling study', Medical Journal of Australia, 220, pp. 243 - 248, http://dx.doi.org/10.5694/mja2.52241
,2024, 'A meta-analysis of previous falls and subsequent fracture risk in cohort studies', Osteoporosis International, 35, pp. 469 - 494, http://dx.doi.org/10.1007/s00198-023-07012-1
,2024, 'Establishing consensus recommendations for long-term osteoporosis care for patients who have attended an Australian fracture liaison service: a Delphi study', Osteoporosis International, 35, pp. 373 - 389, http://dx.doi.org/10.1007/s00198-024-07014-7
,2024, 'Association between Fat Mass and Obesity-Related Transcript Polymorphisms and Osteoporosis Phenotypes', Journal of Bone Metabolism, 31, pp. 48 - 55, http://dx.doi.org/10.11005/jbm.2024.31.1.48
,2024, 'Patient Self-Assessment of Walking Ability and Fracture Risk in Older Australian Adults', JAMA Network Open, 7, http://dx.doi.org/10.1001/jamanetworkopen.2023.52675
,2024, 'Contemporary menopausal hormone therapy and risk of cardiovascular disease: Swedish nationwide register based emulated target trial', BMJ, http://dx.doi.org/10.1136/bmj-2023-078784
,2024, 'Teriparatide as Treatment for Severe Osteoporosis in Lung Transplant Recipients.', JCEM Case Rep, 2, pp. luae026, http://dx.doi.org/10.1210/jcemcr/luae026
,2023, 'Chronic kidney disease-related sarcopenia as a prognostic indicator in elderly haemodialysis patients', BMC Nephrology, 24, http://dx.doi.org/10.1186/s12882-023-03175-5
,2023, 'Denosumab and Mortality in a Real-World Setting: A Comparative Study', Journal of Bone and Mineral Research, 38, pp. 1757 - 1770, http://dx.doi.org/10.1002/jbmr.4930
,2023, 'Effects of bariatric surgery and dietary intervention on insulin resistance and appetite hormones over a 3 year period', Scientific Reports, 13, http://dx.doi.org/10.1038/s41598-023-33317-6
,2023, 'Predicting Slow Walking Speed From a Pooled Cohort Analysis: Sarcopenia Definitions, Agreement, and Prevalence in Australia and New Zealand', Journals of Gerontology Series A Biological Sciences and Medical Sciences, 78, pp. 2415 - 2425, http://dx.doi.org/10.1093/gerona/glad165
,2023, 'Previous fracture and subsequent fracture risk: a meta-analysis to update FRAX', Osteoporosis International, 34, pp. 2027 - 2045, http://dx.doi.org/10.1007/s00198-023-06870-z
,2023, 'Mortality, falls and slow walking speed are predicted by different muscle strength and physical performance measures in women and men', Archives of Gerontology and Geriatrics, 114, http://dx.doi.org/10.1016/j.archger.2023.105084
,2023, 'Prevention of Hip Fractures: Trade-off between Minor Benefits to Individuals and Large Benefits to the Community', Journal of Bone and Mineral Research, 38, pp. 1594 - 1602, http://dx.doi.org/10.1002/jbmr.4907
,2023, 'Genetic Prediction of Lifetime Risk of Fracture.', J Clin Endocrinol Metab, 108, pp. e1403 - e1412, http://dx.doi.org/10.1210/clinem/dgad254
,2023, 'Associations of Type 2 Diabetes, Body Composition, and Insulin Resistance with Bone Parameters: The Dubbo Osteoporosis Epidemiology Study', Jbmr Plus, 7, http://dx.doi.org/10.1002/jbm4.10780
,2023, 'Safer medicines To reduce falls and refractures for OsteoPorosis (#STOP): a study protocol for a randomised controlled trial of medical specialist-initiated pharmacist-led medication management reviews in primary care', BMJ Open, 13, http://dx.doi.org/10.1136/bmjopen-2023-072050
,2023, 'Exploring barriers and opportunities to improve osteoporosis care across the acute-to-primary care interface: a qualitative study', Osteoporosis International, 34, pp. 1249 - 1262, http://dx.doi.org/10.1007/s00198-023-06748-0
,2023, 'Factors associated with fragility fractures in type 2 diabetes: An analysis of the randomised controlled Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study', Diabetes Metabolism Research and Reviews, 39, http://dx.doi.org/10.1002/dmrr.3631
,2023, 'Muscle strength and physical performance contribute to and improve fracture risk prediction in older people: A narrative review', Bone, 172, http://dx.doi.org/10.1016/j.bone.2023.116755
,2023, ''Skeletal Age' for mapping the impact of fracture on mortality', Elife, 12, http://dx.doi.org/10.7554/eLife.83888
,2023, 'Antiresorptive Medication Use Is not Associated with Acute Cardiovascular Risk: An Observational Study', Journal of Clinical Endocrinology and Metabolism, 108, pp. E110 - E119, http://dx.doi.org/10.1210/clinem/dgac669
,2023, 'Contributors to impaired bone health in type 2 diabetes', Trends in Endocrinology and Metabolism, 34, pp. 34 - 48, http://dx.doi.org/10.1016/j.tem.2022.11.003
,2023, 'The association between multimorbidity and osteoporosis investigation and treatment in high-risk fracture patients in Australia: A prospective cohort study', Plos Medicine, 20, http://dx.doi.org/10.1371/journal.pmed.1004142
,2022, 'The role of community pharmacists in delivering interventions for osteoporosis: A systematic review', Journal of the American Pharmacists Association, 62, pp. 1741 - 1749.e10, http://dx.doi.org/10.1016/j.japh.2022.06.014
,